MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    A Parkinson’s Manifesto for Europe

    F. Montague, A. Hursey (Orpington, United Kingdom)

    Objective: To collate the wishes and ambitions of the Parkinson’s community in Europe and create a guide for those working in health care, research and…
  • 2023 International Congress

    Use of concomitant medications before and after treatment with levodopa/carbidopa intestinal gel in patients with advanced Parkinson’s disease: summary of phase 3 and real-world studies

    J. Boyd, H. Fernandez, W. Poewe, A. Fasano, N. Kovács, K. Chaudhuri, M. Simu, J. Aldred, L. Lopiano, S. Parashos, J. Parra, L. Bergmann, P. Kukreja, M. Shah, O. Ladhani, G. Melzi, C. Yan, A. Antonini (Burlington, USA)

    Objective: Evaluate the use of concomitant Parkinson’s disease (PD) medications before and after treatment with levodopa/carbidopa intestinal gel (LCIG) using data from phase 3 clinical…
  • 2023 International Congress

    Risk of Parkinson’s Disease due to Helicobacter Pylori and High Salt Consumption

    V. Balendra (Park Ridge, USA)

    Objective: The association between excessive salt consumption, susceptibility to H. pylori infection and risk of Parkinson's disease will be analyzed through scientific studies. Background: The…
  • 2023 International Congress

    The Role of Adaptive Immunity caused by α-synuclein Recognition Specific Sequence Peptide on the Onset of Parkinson’s Disease Pathogenesis

    MG. Jo, BN. Lee, HM. Seong, SH. Kim, HN. Choi, MG. Kim, SP. Yun (Jinju, Republic of Korea)

    Objective: We investigated whether α-synuclein-derived peptides (recognized specific sequence in α-synuclein) can drive T-cell response and evaluated the neurotoxicity of α-synuclein peptide-specific T-cell in Parkinson’s…
  • 2023 International Congress

    Potentially inappropriate medication useage among patients newly diagnosed with dementia with Lewy bodies

    K. Wyman-Chick, E. Chrenka, M. Barrett, M. Miller, L. Sargent, J. Kuntz, H. Nguyen, A. Werner, Z. Libert, R. Rossom (St Paul, USA)

    Objective: Investigate the use of potentially inappropriate medications (PIM) among patients newly diagnosed with dementia with Lewy bodies (DLB). Background: PIM, including anticholinergics, are associated…
  • 2023 International Congress

    Review of NPO status on admitted PD patient outcomes

    R. Martin (Springfield, USA)

    Objective: To characterize the incidence and severity of outcomes for PD patients admitted to the hospital who miss doses of their medication. Background: PD is…
  • 2023 International Congress

    Therapeutic effects of citral nanoliposome on Parkinson’s treatment in a rat model: Modulation via neurochemical, inflammatory and antioxidant pathways

    N. Moradikor, M. Haghipanah, W. Mohamed (Tbilisi, Georgia)

    Objective: The present study aimed to assess the effects of citral nanoliposome on Parkinson's treatment in a rat model. Background: Parkinson's disease is the most…
  • 2023 International Congress

    Strategic decision-making in Parkinson’s disease with fatigue

    C. Pauletti, D. Mannarelli, F. Milano, A. Maffucci, A. Petritis, F. Fattapposta (Rome, Italy)

    Objective: To assess response inhibition and strategic decision-making abilities associated with fatigue in Parkinson’s disease (PD). Background: PD-related fatigue is defined as a feeling of…
  • 2023 International Congress

    Correlation between Motor Sections of UMSARS and MDS-UPDRS

    S. Castillo-Torres, A. Ferreirós, M. Merello (Buenos Aires, Argentina)

    Objective: To determine the correlation between UMSARS II and MDS-UPDRS III. Background: Despite the availability of the Unified Multiple System Atrophy Rating Scale (UMSARS) [1]…
  • 2023 International Congress

    SARS-CoV-2 infection exacerbates the cellular pathology in Parkinson’s disease progression

    HN. Choi, BN. Lee, YH. Che, MG. Ko, HM. Seong, MG. Jo, KS. Lyoo, YJ. Kim, SP. Yun (Jin-Ju, Republic of Korea)

    Objective: This study can provide an important insight for identification and prediction of long term neurological sequelae of SARS-CoV-2 infection and proper clinical management the…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley